
Efficiency of fluoxetine and alprazolam in the treatment of panic disorder
- 1 Beijing No.4 Highschool International Campus
* Author to whom correspondence should be addressed.
Abstract
Panic disorder, a mental illness that causes panic attacks as the main symptom, is an important subgroup of anxiety and fear disorders, but it has received little attention and research until recent decades. After it was included in the DSM-II in 1980, researchers began studying drug treatments for the disorder. Among the many drugs, the two most effective are 5-HT reuptake inhibitors and benzodiazepines, and the two most representative drugs are fluoxetine and alprazolam. The purpose of this study was to analyze the effectiveness of fluoxetine and alprazolam in the treatment of panic disorder by studying the structure, synthesis, pharmacology and economic benefits of the two drugs, as well as to analyze the methods of clinical use of the drugs.
Keywords
Fluoxetine, Panic disorder, Alprazolam, Mental illness
[1]. Hao, Wei Lu, Lin Li, Tao Liu, Jintong Zhao,Xudong Wang, Gaohua ‘Psychiatry’ People’s Medical Publishing House July 2018 Accessed 18th July 2023
[2]. American Psychiatric Association ‘Diagnostic and Statistical Manual of Mental Disorder, Fifth Edition’ Arlington, VA, American Psychiatric Publishing 2013 Accessed 16th July 2023
[3]. University of Iowa “It’s Greek to Me: Panic” bam.sites.uiowa.edu 20th Mar. 2023 https://bam.sites.uiowa.edu/its-greek-me/panic
[4]. Maudsley, Henry “The Physiology and Pathology of the Mind” Appleton 1867 books.google.com Accessed 20th Jul. 2023 https://books.google.com/books?id=EfY-AAAAYAAJ&vq
[5]. Maudsley, Henry “The Physiology and Pathology of the Mind” Appleton 1867 books.google.com Accessed 20th Jul. 2023 https://books.google.com/books?id=EfY-AAAAYAAJ&vq
[6]. Nardi, Antonio Egidio and Freire, Rafael Christophe R. “The Panic Disorder Concept: a History Perspective” link.springer.com 26th May 2016 https://link.springer.com/chapter/10.1007/978-3-319-12538-1_1
[7]. Na HR, Kang EH, Lee JH, Yu BH. ‘The Genetic Basis of Panic Disorder’ J Korean Med Sci. June 2011 26(6):701-10. doi: 10.3346/jkms.2011.26.6.701. Epub 2011 May 18. PMID: 21655053; PMCID: PMC3102861.
[8]. Hillhouse, Todd M. and Porter, Joseph H. “A Brief History of the Development of Antidepressant Drugs: from Monoamines to Glutamate” www.ncbi.nlm.nih.gov Feb. 2016 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428540/
[9]. Wick, Jeannette Y. “The History of Benzodiazepines” pubmed.ncbi.nlm.nih.gov 28th Sep. 2013 https://pubmed.ncbi.nlm.nih.gov/24007886/
[10]. Pendleton, James ‘Xanax (Alprazolam)’ www.goodtherapy.org Accessed 30th July 2023 https://www.goodtherapy.org/drugs/xanax-alprazolam.html
[11]. NCBI “Fluoxetine” pubchem.ncbi.nlm.nih.gov Accessed 20th Jul. 2023 https ://pubchem.ncbi.nlm.nih.gov/compound/fluoxetine
[12]. Wenthur CJ, Bennett MR, Lindsley CW. Classics in Chemical Neuroscience: Fluoxetine (Prozac). ACS Chem Neurosci. November 2013 9;5(1):14–23. doi: 10.1021/cn400186j. PMCID: PMC3894728.
[13]. NCBI “Alprazolam” pubchem.ncbi.nlm.nih.gov Accessed 20th Jul. 2023 https ://pubchem. ncbi.nlm.nih.gov/compound/2118
[14]. Huzefakifayet ‘Alprazolam Synthesis, SAR, MCQ, Struecture, Chemical Properties and Therapeutic Uses’ gpatindia.com 13th April 2020 https://gpatindia.com/alprazolam-synthesis-sar-mcqstructurechemical-properties-and-therapeutic-uses/
[15]. Sohel, Ahsan J Shutter, Mollie C Molla, Mohammed ‘Fluoxetine’ www.ncbi.nlm.nih.gov 4th July 2022 https://www.ncbi.nlm.nih.gov/books/NBK459223/
[16]. Wikipedia ‘Fluoxetine’ en.wikipedia.org/ Accessed 20th July 2023 https://en.wikipedia.org/wiki/Fluoxetine#Medical_uses
[17]. Michelson D, Lydiard RB, Pollack MH, Tamura RN, Hoog SL, Tepner R, Demitrack MA, Tollefson GD. ‘Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.’ Am J Psychiatry. November 1998 https://pubmed.ncbi.nlm.nih.gov/9812120/
[18]. George, Tobin T. and Tripp, Jayson “Alprazolam” www.ncbi.nlm.nih.gov 24th Apr. 2023 https://www.ncbi.nlm.nih.gov/books/NBK538165/
[19]. Breilmann, J Girlanda, F Guaiana, G Barbui, C Cipriani, A Castellazzi, M Bighelli, I Davies, SJC Furukawa, TA Koesters, M ‘Benzodiazepines for Panic Disorder in Adults’ www.cochrane.org 28th March 2019 https://www.cochrane.org/CD010677/DEPRESSN_benzodiazepines-panic-disorder-adults
[20]. Yang, Baofeng Chen, Jianguo Zang, Jinwei Wei, Minjie ‘Pharmacology’ People’s Medical Publishing House July 2018
[21]. Walker, Leah K ‘Xanax Abuse: Short-and Long-Term Effects of Xanax’ American addictioncenters.org 3rd July 2023 https://americanaddictioncenters.org/xanax-treatment/ long-term-severe
[22]. Drugs.com ‘Fluoxetine Prices, Coupons and Patient Assistance Programs’ www.drugs.com Accessed 25th July 2023 https://www.drugs.com/price-guide/fluoxetine#oral-capsule-20-mg
[23]. Drugs.com ‘Alprazolam Prices, Coupons and Patients Assistance Programs’ www.drugs.com Accessed 25th July 2023 https://www.drugs.com/price-guide/alprazolam#oral-tablet-0-25-mg
Cite this article
Cheng,C. (2024). Efficiency of fluoxetine and alprazolam in the treatment of panic disorder. Theoretical and Natural Science,46,14-22.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 2nd International Conference on Modern Medicine and Global Health
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).